Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
Recruiting · NCT06574126 · Registry updated 2024-10-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma | High Risk Smoldering Multiple Myeloma | Recruiting | Phase 2 | 2024-10-26 | NCT06574126 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PETHEMA Foundation | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clinico Universitario Salamanca | Salamanca | Spain | 5 |